Dr. Brad Smith - Chief Science Officer

Brad Smith, PhD. is Chief Science Officer, meQuilibrium where he leads meQuilibrium’s active science agenda and research function in the pursuit of scientific advancements to help build workforce potential. meQuilibrium is the #1 digital solution for building resilience at scale for Fortune 500 global enterprises, helping businesses innovate and navigate uncertain times. meQuilibrium harnesses the science of resilience, AI, predictive analytics and neuroscience to help businesses build workforce wellbeing and potential. Leading employers have recognized the power of resilience, and meQuilibrium’s intelligent cloud-based resilience-building system, to both mitigate the negative impacts of stress on an individual basis, at scale, but to also build resilient and agile workforce populations capable of thriving in change.

Benefits Think Disruption is a danger to workforce well-being and productivity

Brought about by an extended period of emotional exhaustion and chronic disappointment, pandemic fatigue represents a real threat to both the physical and mental health of our workforce and, ultimately, to our economy.